Publications by authors named "A Abutidze"
Background: With integrase strand transfer inhibitor (INSTI) use associated with increased body mass index (BMI) and BMI increases associated with higher diabetes mellitus (DM) risk, this study explored the relationship between INSTI/non-INSTI regimens, BMI changes, and DM risk.
Methods: RESPOND participants were included if they had CD4, HIV RNA, and ≥ 2 BMI measurements during follow up. Those with prior DM were excluded.
Hepatitis B and hepatitis C are leading causes of cirrhosis and liver cancer and caused 1.3 million deaths worldwide in 2022. Hepatitis B is preventable with vaccination, and hepatitis C is curable with direct-acting antivirals.
View Article and Find Full Text PDFArticle Synopsis
- The study investigates how high-risk COVID-19 patients are managed in the Middle East, Africa, and Eastern Europe, particularly focusing on the use of antiviral therapies amid existing national guidelines.
- During a regional summit in February 2023, healthcare professionals discussed the challenges and practices in treating these patients, emphasizing the uncertain role of primary care physicians as the first point of contact.
- The findings revealed substantial differences in treatment pathways between countries, influenced by local practices, healthcare systems, and resource availability, prompting recommendations for improved care strategies globally.
Objectives: We aimed to assess the extent of integration of non-communicable disease (NCD) assessment and management in HIV clinics across Europe.
Methods: A structured electronic questionnaire with 41 multiple-choice and rating-scale questions assessing NCD assessment and management was sent to 88 HIV clinics across the WHO European Region during March-May 2023. One response per clinic was collected.
Objectives: Georgia introduced remdesivir for the treatment of COVID-19 in December 2020. We evaluated the real-world effect of remdesivir on mortality and the need for mechanical ventilation among inpatients with COVID-19.
Methods: The study included 346 remdesivir recipients and 346 controls not receiving remdesivir selected through propensity score matching based on age, gender, presence of any chronic comorbid condition, and oxygen saturation at admission.